Search results
Results From The WOW.Com Content Network
It now expects earnings per share between $2.15 and $2.35. That's up from previous guidance of between $2.05 and $2.25. The company's dividend is $0.42 per share quarterly, or $1.68 annually. It's ...
The stock won't stay down forever. ... PFE Total Return Level data by YCharts. ... Pfizer's forward price-to-earnings ratio is a measly 10.8. The average for the healthcare industry is 18.3.
This allowed management to hike full-year guidance: Pfizer now expects 2024 adjusted EPS of between $2.45 and $2.65, compared to a prior $2.25 midpoint estimate. The revenue forecast was also ...
Price Action: PFE stock is up 1.60% at $31.21 during the premarket session at the last check on Tuesday. Read Next: With Oral Anti-Obesity Candidate Development, ...
Pfizer Inc. ( / ˈfaɪzər / FY-zər) [ 3] is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).
In fact, investors traded out of the stock to the point that its price fell by 1.4%, comparing unfavorably to the 0.2% rise of the S&P 500 index on the day. Combination vaccine falls short in ...
Pfizer (NYSE: PFE) is being unfairly ignored by some investors, ... its depressed stock price (recently down about 51% since late 2021) has pushed up its dividend yield to a recent 5.7%. Even ...
June 4, 2024 at 5:29 AM. Pfizer (NYSE: PFE) investors have been through a lot of ups and downs over the past few years. If you've been on the sidelines, now could be a great time to buy the stock ...